#Sustainability #GenScript Biotech #MSCI ESG

GenScript Biotech Achieves a Historic Upgrade in ESG Rating

On July 31, 2025, GenScript Biotech Corporation, a prominent player in the life sciences sector, announced a significant milestone in its sustainability journey. The global provider of research and manufacturing services in biotechnology received an upgrade from MSCI, one of the leading index providers, to AA in its Environmental, Social, and Governance (ESG) ratings. This achievement underscores GenScript's commitment to excelling in product safety, quality, and human capital development, while also prioritizing continuous improvements in governance and environmental practices.

MSCI rates companies based on their exposure to ESG risks, providing a benchmark for investors and the global market. Their ratings range from CCC, indicating poor performance, to AAA, marking industry leaders. With its new AA rating, GenScript not only solidifies its position as a leader in sustainability within the biotech field but also affirms its dedication to responsible business models that align with long-term financial success.

Leadership's Vision for Sustainable Growth

Sherry Shao, the Rotating CEO of GenScript Biotech, expressed her optimism regarding the company's future. “The AA rating from a globally recognized index is a testament to GenScript's ESG performance. By embedding sustainability into our core business practices, we not only enhance our operational resilience but also create lasting value for our investors and stakeholders worldwide,” she remarked.

Shao emphasized the company’s mission to innovate and pursue sustainable industry growth, declaring, “We will continue to catalyze our efforts, pushing the boundaries to drive growth aligned with our mission to 'Make People and Nature Healthier through Biotechnology.'”

Commitment to Responsible Practices

GenScript's upgrade acknowledges the company's ongoing pursuit of responsible business practices. As a proud member of the United Nations Global Compact (UNGC), GenScript adheres to essential principles concerning human rights, labor standards, environmental protection, and anti-corruption measures. Furthermore, the company has collaborated with the Pharmaceutical Supply Chain Initiative (PSCI), promoting sustainable value chains in the pharmaceutical industry.

This year alone has seen GenScript achieve acknowledgment from various prestigious organizations. The firm received a Silver Medal from EcoVadis, ranking amongst the top 15% globally for sustainability performance. In addition to this, it earned a